Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
Masitinib is being studied for several human conditions including cancers and Amyotrophic lateral sclerosis.[3][4] It is used in Europe for orphan diseases.
- ProName: MASITINIB Ab-1010
- CasNo:790299-79-5
- Molecular Formula: C28H30N6OS
- Appearance: Light yellow transparent liquid
- Application: CAS：790299-79-5，MASITINIB;
- DeliveryTime: 3 months
- PackAge: 100g,500,1kg
- Port: shang hai
- ProductionCapacity: 1000 Metric Ton/Month
- Purity: 98%
- Storage: Dry seal
- LimitNum: 100 Gram
No comments:
Post a Comment